Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)

  • STATUS
    Recruiting
  • End date
    Nov 28, 2029
  • participants needed
    600
  • sponsor
    Institut du Cancer de Montpellier - Val d'Aurelle
Updated on 19 February 2024
cancer

Summary

The creation of a prospective clinical-biological base dedicated to peritoneal carcinosis must therefore be able to serve as a support for this essential search for transfer.

Description

The main objective is to improve the knowledge of carcinocis mechanisms to develop a specific treatment.

That's why this blood collection and tissue collection is very important for the future, these collection will be permitted to the scientists to develop a research specially for carcinosis.

Details
Condition Cancer, Peritoneal Carcinosis
Age 18-100 years
Treatment Biological collection, Tissues collections
Clinical Study IdentifierNCT04221464
SponsorInstitut du Cancer de Montpellier - Val d'Aurelle
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Patient over the age of 18
Patient managed for peritoneal carcinosis : digestives origins (pancreatic, esogastric, colorectal, bowel) or peritoneum cancer
Patient eligible for a peritoneal carcinosis treatment : at least one (or more) surgery (s) ;chemotherapy or any treatment for this disease
Patient agree will all study procedure : biological samples & tissues samples
Patient giving informed consent

Exclusion Criteria

Patient not affiliated to Social Protection system
Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons
The level of French is insufficient to consent to the study and to response to the questionnaires
Patient under guardianship
Pregnacy ou breast-feeding women
Patient treated in case of an emergency
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.